| D008297 |
Male |
|
Males |
|
| D005260 |
Female |
|
Females |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000900 |
Anti-Bacterial Agents |
Substances that inhibit the growth or reproduction of BACTERIA. |
Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial |
|
| D012293 |
Rifampin |
A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) |
Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin |
|
| D013203 |
Staphylococcal Infections |
Infections with bacteria of the genus STAPHYLOCOCCUS. |
Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections |
|
| D017287 |
Ventriculoperitoneal Shunt |
Surgical creation of a communication between a cerebral ventricle and the peritoneum by means of a plastic tube to permit drainage of cerebrospinal fluid for relief of hydrocephalus. (From Dorland, 28th ed) |
Ventriculo-peritoneal Shunt,Shunt, Ventriculo-peritoneal,Shunt, Ventriculoperitoneal,Shunts, Ventriculo-peritoneal,Shunts, Ventriculoperitoneal,Ventriculo peritoneal Shunt,Ventriculo-peritoneal Shunts,Ventriculoperitoneal Shunts |
|
| D055499 |
Catheter-Related Infections |
Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection. |
Catheter Associated Infection,Catheter Related Infection,Catheter-Associated Infections,Associated Infection, Catheter,Associated Infections, Catheter,Catheter Associated Infections,Catheter Related Infections,Catheter-Associated Infection,Catheter-Related Infection,Infection, Catheter Associated,Infection, Catheter Related,Infection, Catheter-Associated,Infection, Catheter-Related,Infections, Catheter Associated,Infections, Catheter Related,Infections, Catheter-Associated,Infections, Catheter-Related,Related Infection, Catheter,Related Infections, Catheter |
|